Straight from the FDA website....perhaps they are not telling the truth also:
Phase 3
Study Participants: 300 to 3,000 volunteers who have the disease or condition Length of Study: 1 to 4 years Purpose: Efficacy and monitoring of adverse reactions
Approximately 25-30% of drugs move to the next phase